摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-氟苯乙酮肟 | 329-79-3

中文名称
4-氟苯乙酮肟
中文别名
——
英文名称
1-(4-fluorophenyl)ethanone oxime
英文别名
4-fluoroacetophenone oxime;1-(4-fluorophenyl)ethan-1-one oxime;p-fluoroacetophenone oxime;p-Fluoracetophenonoxim;N-[1-(4-fluorophenyl)ethylidene]hydroxylamine
4-氟苯乙酮肟化学式
CAS
329-79-3
化学式
C8H8FNO
mdl
MFCD01673175
分子量
153.156
InChiKey
YPFOSEYKSLTSSF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    72-74 °C
  • 沸点:
    239.8±23.0 °C(Predicted)
  • 密度:
    1.12±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    32.6
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 海关编码:
    2928000090

SDS

SDS:604b66e994ff57a72cfd712cb94409d8
查看
Name: 4-Fluoroacetophenone oxime 98% Material Safety Data Sheet
Synonym:
CAS: 329-79-3
Section 1 - Chemical Product MSDS Name:4-Fluoroacetophenone oxime 98% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
329-79-3 4-Fluoroacetophenone oxime 98% unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 329-79-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 72 - 74 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density:
Molecular Formula: C8H8FNO
Molecular Weight: 153.16

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 329-79-3: AM8505000 LD50/LC50:
CAS# 329-79-3: Oral, mouse: LD50 = 1500 mg/kg.
Carcinogenicity:
4-Fluoroacetophenone oxime - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 329-79-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 329-79-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 329-79-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-氟苯乙酮肟氧气 作用下, 以 乙腈 为溶剂, 60.0 ℃ 、101.33 kPa 条件下, 反应 2.0h, 以97%的产率得到4-氟苯乙酮
    参考文献:
    名称:
    含亚硝酸盐树脂作为有效且可回收的催化剂,用于将肟有氧氧化成羰基化合物
    摘要:
    摘要 使用新型含亚硝酸盐树脂作为 NO 源,Amberlyst-15 作为助催化剂,我们开发了以分子氧作为清洁氧化剂将肟有氧氧化成相应羰基化合物的方法。与之前的相关报道不同,实验结果表明加水明显降低了产量。该工艺为氧化脱肟提供了更好的选择,具有收率高、程序简单、催化性能高、催化剂可回收等优点。图形概要
    DOI:
    10.1080/00397911.2016.1211290
  • 作为产物:
    描述:
    4-氟苯乙酮盐酸羟胺sodium acetate 作用下, 以 乙醇 为溶剂, 生成 4-氟苯乙酮肟
    参考文献:
    名称:
    钯催化芳族肟的CH官能化:合成异喹啉的策略
    摘要:
    报道了通过Pd(II)催化肟与叠氮化物的环化反应或肟的均偶联反应合成异喹啉的有效策略。肟可以在转化过程中充当导向基团和内部氧化剂。该反应具有良好的官能团耐受性,并为在温和条件下合成不同种类的异喹啉提供了有用的方案。为进行机理研究,进行了一些对照实验和15 N同位素标记实验。
    DOI:
    10.1021/acs.joc.5b02376
点击查看最新优质反应信息

文献信息

  • Iron-Catalyzed Synthesis of 2<i>H</i>-Imidazoles from Oxime Acetates and Vinyl Azides under Redox-Neutral Conditions
    作者:Zhongzhi Zhu、Xiaodong Tang、Jianxiao Li、Xianwei Li、Wanqing Wu、Guohua Deng、Huanfeng Jiang
    DOI:10.1021/acs.orglett.7b00203
    日期:2017.3.17
    A novel and versatile method for the synthesis of 2H-imidazoles via iron-catalyzed [3 + 2] annulation from readily available oxime acetates with vinyl azides has been developed. This denitrogenative process involved N–O/N–N bond cleavages and two C–N bond formations to furnish 2,4-substituted 2H-imidazoles. This protocol was performed under mild reaction conditions and needed no additives or ligands
    已开发出一种新颖且通用的方法,该方法通过铁催化的[3 + 2]环合反应从易于获得的肟肟与叠氮化乙烯中合成2 H-咪唑。该脱氮过程涉及N–O / N–N键断裂和两个C–N键形成,以提供2,4-取代的2 H-咪唑。该方案在温和的反应条件下进行,不需要添加剂或配体。此外,这是绿色反应,涉及乙酸肟肟作为内部氧化剂,乙酸和氮作为副产物。
  • SO<sub>2</sub> F<sub>2</sub> -Activated Efficient Beckmann Rearrangement of Ketoximes for Accessing Amides and Lactams
    作者:Guofu Zhang、Yiyong Zhao、Lidi Xuan、Chengrong Ding
    DOI:10.1002/ejoc.201900844
    日期:2019.8.15
    A novel protocol for the efficient activation of the Beckmann rearrangement utilizing the readily available sulfuryl fluoride (SO2F2 gas) is reported. The substrate scope of this methodology has been demonstrated by 37 examples with good to nearly quantitative isolated yields in a short time. A tentative mechanism was proposed involving formation and elimination of sulfonyl ester.
    报道了一种利用容易获得的硫酰氟(SO 2 F 2气体)有效激活贝克曼重排的新方案。该方法的底物范围已通过37个实例证明,并在短时间内获得了良好至近乎定量的分离产率。提出了一种尝试性的机制,涉及形成和消除磺酰基酯。
  • Synthesis of Air- and Moisture-Stable, Storable Chiral Oxorhenium Complexes and Their Application as Catalysts for the Enantioselective Imine Reduction
    作者:Braja Gopal Das、Rajender Nallagonda、Dhananjay Dey、Prasanta Ghorai
    DOI:10.1002/chem.201501914
    日期:2015.9.1
    salicyloxazoline based oxorhenium(V) complexes have been synthesized and their catalytic application for the asymmetric reduction of ketimines using hydrosilane as hydride source is disclosed. A broad substrate scope, high yields, and excellent enantioselectivities (up to 99 %) are attained. Furthermore, the syntheses of enantiopure α‐amino esters, γ‐ and δ‐lactams, and isoindolinones have also been carried
    合成了空气/水分稳定,晶体和可储存的手性水杨基恶唑啉基氧化(V)配合物,并公开了其在氢化硅烷作为氢化物源的情况下催化不对称还原酮亚胺的催化应用。获得了广泛的底物范围,高收率和出色的对映选择性(最高99%)。此外,对映体纯α-氨基酯,γ-和δ-内酰胺以及异吲哚啉酮的合成也已使用该方法进行。最后,该方法已应用于具有药物相关性的合成靶标,例如R -(+)-沙丁胺碱和R -(+)-crispine A.
  • Copper-catalyzed synthesis of thiazol-2-yl ethers from oxime acetates and xanthates under redox-neutral conditions
    作者:Zhongzhi Zhu、Xiaodong Tang、Jinghe Cen、Jianxiao Li、Wanqing Wu、Huanfeng Jiang
    DOI:10.1039/c8cc00445e
    日期:——
    acetates and xanthates for the synthesis of thiazol-2-yl ethers with remarkable regioselectivity has been developed. Various oxime acetates, whether derived from aryl ketones or alkyl ketones, or natural product cores are suitable for this conversion. Unique dihydrothiazoles were also obtained when both reaction sites were methine. Mechanistic studies indicated that imino copper(III) intermediates were involved
    新型的铜催化的肟肟酸酯和黄药酸酯的环化反应用于合成噻唑-2-基醚,具有显着的区域选择性。各种衍生自芳基酮或烷基酮的乙酸肟酯,或天然产物核均适用于该转化。当两个反应位点均为次甲基时,也获得了独特的二氢噻唑。机理研究表明,涉及亚氨基铜(III)中间体。另外,该方案在氧化还原中性条件下进行,不需要添加剂或配体。
  • Catalytic Enantio- and Diastereoselective Mannich Addition of TosMIC to Ketimines
    作者:Allegra Franchino、Jack Chapman、Ignacio Funes-Ardoiz、Robert S. Paton、Darren J. Dixon
    DOI:10.1002/chem.201804099
    日期:2018.12.3
    pharmaceutical and agrochemical sectors, as well as in catalysis. Catalytic asymmetric Mannich additions represent a valuable method to access such compounds in enantioenriched form. This work reports the first enantio‐ and diastereoselective addition of commercially available p‐toluenesulfonylmethyl isocyanide (TosMIC) to ketimines, affording 2‐imidazolines bearing two contiguous stereocenters, one of which
    在α位置带有立体中心的手性胺是无处不在的化合物,在制药和农业化学领域以及催化领域具有许多应用。催化不对称曼尼希添加剂代表了一种有价值的方法,可通过对映体富集的形式获得此类化合物。这项工作报道了市售p的首次对映体和非对映体选择性甲苯磺酰基甲基异氰化物(TosMIC)转化为酮亚胺,提供带有两个连续立体中心的2-咪唑啉,其中一个被完全取代,具有高收率和出色的立体控制。该反应由氧化银和二氢奎宁衍生的N,P-配体催化,适用范围广,操作简单且可扩展。产品的衍生化提供了对映体富集的邻二胺,NHC配体的前体和富含sp 3的杂环支架。计算用于理解催化作用和合理化立体选择性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐